Work

Abstract CT110: Phase II multicenter study of gene-mediated cytotoxic immunotherapy as an adjuvant to surgical resection for newly diagnosed malignant glioma: lessons learned from pseudo-progression and a nine-year survivor

Year: 2016

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2016-ct110

Authors: David S. Baskin, Laura K. Aguilar, Lee A. Wheeler, Andrea G. Manzanera, Susan D. Bell, Robert Cavaliere, John M. McGregor, Simon S. Lo, John C. Grecula, Herbert B. Newton, Behnam Badie, Bin S. Teh, Edward Brian Butler, Todd W. Trask, Jana Portnow, Pamela Z. New, Estuardo Aguilar-Cordova, E. Antonio Chiocca

Institutions: Houston Methodist, Advantagene (United States), Brigham and Women's Hospital, Harvard University, The Ohio State University, University Hospitals Seidman Cancer Center, Case Western Reserve University, City Of Hope National Medical Center

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2487949953

Cites:

Cited by:

Related to: 10